Emmanuel Macron is expected to say more about the upcoming vaccination campaign against Covid-19, during the speech scheduled for Tuesday, November 24.
An envelope of 1.5 billion euros has been released, without knowing whether this will be sufficient. It must be said that a price battle is also at the heart of negotiations with laboratories. According to the government, it will cost 5 euros and 25 euros per dose of vaccine, depending on the laboratory. And France is determined to get a very good price.
A well-conducted group negotiation
The Minister for Industry, Agnès Pannier-Runacher, assures us that he “It is not impossible that we have better prices than the Americans, because we have been able to negotiate as a group”. Indeed, from the start of the discussions, France joined forces with six other countries to negotiate on behalf of the European Union, and to pre-order a large quantity of vaccines. Thus, with the economies of scale achieved, the laboratories can sell the vaccine at a lower cost.
To date, Moderna and Pfizer announce vaccines that are over 90% effective, while AstraZeneca is 70% effective. “Please note, these are intermediate results, and in addition there were two protocols, two vaccine schedules used by AstraZeneca. A first scheme in which an efficiency was obtained which was 62%, and a second scheme in which an efficiency of 90% was obtained ”, explains journalist and doctor Damien Mascret on the set.